Ellis I - Search Results

1

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.

Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. Garcia MJ, et al. Among authors: ellis i. Oncogene. 2005 Aug 4;24(33):5235-45. doi: 10.1038/sj.onc.1208741. Oncogene. 2005. PMID: 15897872

2

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO. Abd El-Rehim DM, et al. Among authors: ellis io. J Pathol. 2004 Jun;203(2):661-71. doi: 10.1002/path.1559. J Pathol. 2004. PMID: 15141381

3

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Putti TC, et al. Mod Pathol. 2005 Jan;18(1):26-35. doi: 10.1038/modpathol.3800255. Mod Pathol. 2005. PMID: 15332092 Free article.

4

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Int J Cancer. 2005 May 1;114(5):720-9. doi: 10.1002/ijc.20738. Int J Cancer. 2005. PMID: 15609312

5

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. Abd El-Rehim DM, et al. Int J Cancer. 2005 Sep 1;116(3):340-50. doi: 10.1002/ijc.21004. Int J Cancer. 2005. PMID: 15818618

6

Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.

Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C. Callagy GM, et al. Clin Cancer Res. 2006 Apr 15;12(8):2468-75. doi: 10.1158/1078-0432.CCR-05-2719. Clin Cancer Res. 2006. PMID: 16638854 Free article.

7

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO. Rakha EA, et al. Eur J Cancer. 2006 Dec;42(18):3149-56. doi: 10.1016/j.ejca.2006.08.015. Epub 2006 Oct 19. Eur J Cancer. 2006. PMID: 17055256

8

A consensus prognostic gene expression classifier for ER positive breast cancer.

Teschendorff AE, Naderi A, Barbosa-Morais NL, Pinder SE, Ellis IO, Aparicio S, Brenton JD, Caldas C. Teschendorff AE, et al. Genome Biol. 2006;7(10):R101. doi: 10.1186/gb-2006-7-10-r101. Epub 2006 Oct 31. Genome Biol. 2006. PMID: 17076897 Free PMC article.

9

BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.

Naderi A, Teschendorff AE, Beigel J, Cariati M, Ellis IO, Brenton JD, Caldas C. Naderi A, et al. Cancer Res. 2007 Jul 15;67(14):6725-36. doi: 10.1158/0008-5472.CAN-06-4394. Cancer Res. 2007. PMID: 17638883

10

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO. Elsheikh S, et al. Breast Cancer Res Treat. 2008 May;109(2):325-35. doi: 10.1007/s10549-007-9659-8. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,068 results

Search Page

Filters